• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of correspondence responded to within the month

Dictionary: The Office of the Center Director is responsible for answering the public's and Congress’ questions about the work done by FDA/CVM. This measure tracks the Office of the Center Director’s timeliness in completing referrals as tracked by the AIMS system and Office of Legislation which are related to all Congressional correspondence. Congressional correspondences include: general information requests, constituent related requests, letters expressing concerns from Congress, questions for the record related to hearings, briefing requests, technical and document requests.

The Office of the Center Director is responsible for answering the public's questions about the work done by FDA/CVM. This measure tracks the Office of the Center Director’s timeliness in completing referrals related to all non-Congressional correspondence. Non-Congressional letter correspondences include: public inquiries received by the Secretary, Commissioner, and Center Director regarding: general information requests, expertise of a specific subject/issue, pre and post approvals, hot topic items, and any other CVM related issues.

Information is current as of December 31, 2014.

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetPercent
Oct 201495116
Nov 201495100
Dec 201495117
Jan 201595TBD
Feb 201595TBD
Mar 201595TBD
Apr 201595TBD
May 201595TBD
Jun 201595TBD
Jul 201595TBD
Aug 201595TBD
Sep 201595TBD

FY 2015 YTD: 100%

Total number of correspondence received within the month

Fiscal Year - 2015
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2014N/A19
Nov 2014N/A20
Dec 2014N/A12
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 51

Total number of correspondence responded to within the month

Fiscal Year - 2015
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2014N/A22
Nov 2014N/A20
Dec 2014N/A14
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 56

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.